Therapeutic challenges in hepatitis C-infected inj...[Harm Reduct J. 2006]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Harm Reduct J. 2006 Nov 10;3:31. Links

Therapeutic challenges in hepatitis C-infected injection drug using patients.

Cooper CL, Mills EJ.

Ottawa Hospital, Division of Infectious Diseases, Canada. ccooper@ottawahospital.on.ca

Hepatitis C Viral (HCV) infection in the injection drug user (IDU) population is a major medical concern. Concurrent substance abuse, co-morbid mental health conditions, poor socioeconomic status and a complex treatment protocol that is often incompatible with the life styles of IDUs combine to account for poor uptake and completion of HCV treatment. This article discusses HCV antiviral treatment issues relevant to IDUs chronically infected with this virus. The effect of non-injected substances of abuse on treatment outcome is considered. Priority issues requiring research are discussed.

PMID: 17096852 [PubMed]

PMCID: PMC1664558

ReviewObstacles to successful HCV treatment in substance addicted patients.
J Addict Dis. 2008; 27(2):61-8.

[J Addict Dis. 2008]
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.
J Urban Health. 2004 Dec; 81(4):719-34.

[J Urban Health. 2004]
ReviewEpidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Public Health. 2008 Oct; 122(10):990-1003. Epub 2008 May 19.

[Public Health. 2008]
ReviewIntegrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Int J Drug Policy. 2007 Oct; 18(5):417-25. Epub 2007 Feb 20.

[Int J Drug Policy. 2007]
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
Int J Drug Policy. 2007 Oct; 18(5):437-43. Epub 2007 Apr 27.

[Int J Drug Policy. 2007]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Therapeutic challenges in hepatitis C-infected injection drug using patients.Therapeutic challenges in hepatitis C-infected injection drug using patients.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Therapeutic challenges in hepatitis C-infected injection drug using patients.

Related articles

Recent Activity